Julie L. Engers

933 citations

48 papers · 634 indexed · h-index 15

Co-authors: Craig W. Lindsley P. Jeffrey Conn Colleen M. Niswender Max E. Joffe Kyle A. Emmitte Anna L. Blobaum Alice L. Rodriguez Sichen Chang
Topics: Receptor Mechanisms and Signaling (26 papers)Neuroscience and Neuropharmacology Research (25 papers)Ion channel regulation and function (9 papers)
Cited by: Biological Psychiatry Cellular and Molecular Neuroscience Behavioral Neuroscience
Journals: Neuron The FASEB Journal Journal of Medicinal Chemistry
Partner nations: United States Denmark Italy

In The Last Decade

Julie L. Engers

44 papers receiving 633 citations

Peers

Countries citing papers authored by Julie L. Engers

Since Specialization

Citations

This map shows the geographic impact of Julie L. Engers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie L. Engers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie L. Engers more than expected).

Fields of papers citing papers by Julie L. Engers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie L. Engers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie L. Engers. The network helps show where Julie L. Engers may publish in the future.

Co-authorship network of co-authors of Julie L. Engers

This figure shows the co-authorship network connecting the top 25 collaborators of Julie L. Engers. A scholar is included among the top collaborators of Julie L. Engers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie L. Engers. Julie L. Engers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Application of Deuterium in an M₁ Positive Allosteric Modulator Back-Up Program: The Discovery of VU6045422 2025 ·ACS Chemical Neuroscience ·Julie L. Engers,(unknown),Changho Han,(unknown),Alison R. Gregro,(unknown),Jonathan W. Dickerson,Weimin Peng,Hyekyung P. Cho,Alice L. Rodriguez,Zixiu Xiang,Olivier Boutaud,C. O’Carroll,Prabuddha Dey,Ethan S. Burstein,Colleen M. Niswender,Jerri M. Rook,P. Jeffrey Conn,Darren W. Engers,Craig W. Lindsley	0
2	Discovery of a Novel sp³-Rich M₁ Positive Allosteric Modulators (PAMs) Chemotype via Scaffold Hopping 2025 ·ACS Medicinal Chemistry Letters ·(unknown),Paul K. Spearing,(unknown),(unknown),(unknown),Sichen Chang,(unknown),Analisa D. Thompson,Hyekyung P. Cho,Peng Li,Alice L. Rodriguez,Colleen M. Niswender,Olivier Boutaud,Valerie M. Kramlinger,Carrie K. Jones,P. Jeffrey Conn,Julie L. Engers,Darren W. Engers,Craig W. Lindsley,Changho Han	0
3	Total Synthesis and Pharmacological Evaluation of Phochrodines A–C 2025 ·Journal of Natural Products ·(unknown),Sichen Chang,Krishnan Srinivasan,(unknown),Olivier Boutaud,Nathan D. Schley,Darren W. Engers,Julie L. Engers,Craig W. Lindsley,Aaron M. Bender	0
4	Discovery of VU6007496: Challenges in the Development of an M₁ Positive Allosteric Modulator Backup Candidate 2024 ·ACS Chemical Neuroscience ·Julie L. Engers,(unknown),(unknown),(unknown),Aaron M. Bender,Jonathan W. Dickerson,Weimin Peng,(unknown),Hyekyung P. Cho,Alice L. Rodriguez,Colleen M. Niswender,Sean P. Moran,Zixiu Xiang,Anna L. Blobaum,Olivier Boutaud,(unknown),Darren W. Engers,P. Jeffrey Conn,Craig W. Lindsley	3
5	Discovery of VU6008677: A Structurally Distinct Tricyclic M₄ Positive Allosteric Modulator with Improved CYP450 Profile 2024 ·ACS Medicinal Chemistry Letters ·(unknown),(unknown),Julie L. Engers,(unknown),Sichen Chang,Vincent B. Luscombe,Alice L. Rodriguez,Colleen M. Niswender,Thomas M. Bridges,Olivier Boutaud,P. Jeffrey Conn,Darren W. Engers,Craig W. Lindsley,Kayla J. Temple	2
6	Discovery of VU6016235: A Highly Selective, Orally Bioavailable, and Structurally Distinct Tricyclic M₄ Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) 2024 ·ACS Chemical Neuroscience ·Julie L. Engers,(unknown),Sichen Chang,Vincent B. Luscombe,Alice L. Rodriguez,Colleen M. Niswender,Hyekyung P. Cho,Michael Bubser,(unknown),Carrie K. Jones,Weimin Peng,Jerri M. Rook,Thomas M. Bridges,Olivier Boutaud,P. Jeffrey Conn,Darren W. Engers,Craig W. Lindsley,Kayla J. Temple	1
7	Development of a Selective and High Affinity Radioligand, [3H]VU6013720, for the M4 Muscarinic Receptor 2023 ·Molecular Pharmacology ·Aidong Qi,(unknown),(unknown),Alice L. Rodriguez,Peng Li,Jonathan W. Dickerson,Julie L. Engers,Aaron M. Bender,Mark S. Moehle,Craig W. Lindsley,Jerri M. Rook,Colleen M. Niswender	2
8	Discovery of structurally distinct tricyclic M4 positive allosteric modulator (PAM) chemotypes – Part 2 2021 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),Paul K. Spearing,Julie L. Engers,Alison R. Gregro,(unknown),Sichen Chang,Vincent B. Luscombe,Alice L. Rodriguez,Hyekyung P. Cho,Colleen M. Niswender,Thomas M. Bridges,P. Jeffrey Conn,Craig W. Lindsley,Darren W. Engers,Kayla J. Temple	4
9	mGlu2 and mGlu3 Negative Allosteric Modulators Divergently Enhance Thalamocortical Transmission and Exert Rapid Antidepressant-like Effects 2019 ·Neuron ·Max E. Joffe,(unknown),(unknown),James Maksymetz,(unknown),Julie L. Engers,Craig W. Lindsley,Danny G. Winder,P. Jeffrey Conn	58
10	Discovery of a novel 3,4-dimethylcinnoline carboxamide M4 positive allosteric modulator (PAM) chemotype via scaffold hopping 2019 ·Bioorganic & Medicinal Chemistry Letters ·Kayla J. Temple,Julie L. Engers,(unknown),Alison R. Gregro,(unknown),Sichen Chang,(unknown),Vincent B. Luscombe,Alice L. Rodriguez,Colleen M. Niswender,Thomas M. Bridges,P. Jeffrey Conn,Darren W. Engers,Craig W. Lindsley	9
11	Discovery of a novel 2,3-dimethylimidazo[1,2-a]pyrazine-6-carboxamide M4 positive allosteric modulator (PAM) chemotype 2019 ·Bioorganic & Medicinal Chemistry Letters ·Kayla J. Temple,Julie L. Engers,(unknown),(unknown),Sichen Chang,Vincent B. Luscombe,(unknown),Alice L. Rodriguez,Colleen M. Niswender,Thomas M. Bridges,P. Jeffrey Conn,Darren W. Engers,Craig W. Lindsley	4
12	Discovery of structurally distinct tricyclic M4 positive allosteric modulator (PAM) chemotypes 2019 ·Bioorganic & Medicinal Chemistry Letters ·Kayla J. Temple,(unknown),Julie L. Engers,(unknown),Sichen Chang,Vincent B. Luscombe,Alice L. Rodriguez,Colleen M. Niswender,Thomas M. Bridges,P. Jeffrey Conn,Darren W. Engers,Craig W. Lindsley	6
13	Mechanisms underlying prelimbic prefrontal cortex mGlu3/mGlu5-dependent plasticity and reversal learning deficits following acute stress 2018 ·Neuropharmacology ·Max E. Joffe,(unknown),Branden J. Stansley,James Maksymetz,Rocco G. Gogliotti,Julie L. Engers,Ferdinando Nicoletti,Craig W. Lindsley,P. Jeffrey Conn	47
14	Discovery and characterization of N-(1,3-dialkyl-1H-indazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine scaffold as mGlu4 positive allosteric modulators that mitigate CYP1A2 induction liability 2018 ·Bioorganic & Medicinal Chemistry Letters ·Darren W. Engers,(unknown),Julie L. Engers,Joseph D. Panarese,(unknown),Alison R. Gregro,Anna L. Blobaum,Joanne J. Bronson,Yong‐Jin Wu,John E. Macor,Alice L. Rodriguez,Rocio Zamorano,P. Jeffrey Conn,Craig W. Lindsley,Colleen M. Niswender,Corey R. Hopkins	8
15	Discovery of a novel 2,4-dimethylquinoline-6-carboxamide M4 positive allosteric modulator (PAM) chemotype via scaffold hopping 2017 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Julie L. Engers,Sichen Chang,Xiaoyan Zhan,Rebecca L. Weiner,Vincent B. Luscombe,Alice L. Rodriguez,Hyekyung P. Cho,Colleen M. Niswender,Thomas M. Bridges,P. Jeffrey Conn,Darren W. Engers,Craig W. Lindsley	14
16	Metabotropic glutamate receptor subtype 3 gates acute stress-induced dysregulation of amygdalo-cortical function 2017 ·Molecular Psychiatry ·Max E. Joffe,(unknown),Julie L. Engers,Craig W. Lindsley,P. Jeffrey Conn	37
17	Substituted indoles as selective protease activated receptor 4 (PAR-4) antagonists: Discovery and SAR of ML354 2014 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),Matthew T. Duvernay,M. Schulte,Kellie D. Nance,Bruce J. Melancon,Julie L. Engers,Charles W. Locuson,(unknown),J. Scott Daniels,Wenjun Wu,Craig W. Lindsley,Heidi E. Hamm,Shaun R. Stauffer	29
18	Discovery of (R)-(2-Fluoro-4-((-4-methoxyphenyl)ethynyl)phenyl) (3-Hydroxypiperidin-1-yl)methanone (ML337), An mGlu₃ Selective and CNS Penetrant Negative Allosteric Modulator (NAM) 2013 ·Journal of Medicinal Chemistry ·Cody J. Wenthur,Ryan D. Morrison,Andrew S. Felts,(unknown),Julie L. Engers,Frank W. Byers,J. Scott Daniels,Kyle A. Emmitte,P. Jeffrey Conn,Craig W. Lindsley	47
19	Discovery of ML326: The first sub-micromolar, selective M5 PAM 2013 ·Bioorganic & Medicinal Chemistry Letters ·Patrick R. Gentry,Thomas M. Bridges,Atin Lamsal,Paige N. Vinson,Emery Smith,Peter Chase,Peter Hodder,Julie L. Engers,Colleen M. Niswender,J. Scott Daniels,P. Jeffrey Conn,Michael R. Wood,Craig W. Lindsley	20
20	Discovery of a new molecular probe ML228: An activator of the hypoxia inducible factor (HIF) pathway 2011 ·Bioorganic & Medicinal Chemistry Letters ·Jimmy R. Thériault,Andrew S. Felts,(unknown),José R. Perez,Michelle Palmer,Shawn R. Gilbert,Eric S. Dawson,Julie L. Engers,Craig W. Lindsley,Kyle A. Emmitte	24

About Julie L. Engers

Julie L. Engers is a scholar working on Cellular and Molecular Neuroscience, Biological Psychiatry and Behavioral Neuroscience, having authored 48 papers that have together received 634 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (26 papers), Neuroscience and Neuropharmacology Research (25 papers) and Ion channel regulation and function (9 papers). The work is most often cited by research in Biological Psychiatry (68 citations), Cellular and Molecular Neuroscience (393 citations) and Behavioral Neuroscience (35 citations). Julie L. Engers has collaborated with scholars based in United States, Denmark and Italy. Frequent co-authors include Craig W. Lindsley, P. Jeffrey Conn, Colleen M. Niswender, Max E. Joffe, Kyle A. Emmitte, Anna L. Blobaum, Alice L. Rodriguez, Sichen Chang, J. Scott Daniels and Ryan D. Morrison. Their work appears in journals such as Neuron, The FASEB Journal and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact